PHARMACO-ECONOMICAL ASPECTS OF IN-PATIENT TREATMENT OF CHILDREN WITH PERINATAL

Pediatričeskaâ Farmakologiâ

O.M. Zubov¹  I.V. Kareva¹  N.I. Grevtseva¹  N.M. Sudakova² 

[1] Belgorod Municipal Children Hospital;National Research University «Belgorod State University», Belgorod;

关键词: perinatal encephalopathy;    abc-analysis;    ven-analysis;   

DOI  :  10.15690/pf.v9i1.157

来源: DOAJ

【 摘 要 】

The results of expert analyses АВС–VEN of drugs, using in treatment of children with perinatal encephalopathy at the age of 7 days to 3 years in psycho-neurological department of MIH «Belgorod Municipal children hospital» are represented in this study. The research is performed accounting syndrome approach to the diagnosis. It was established, that in the groups with the most financial costs («A» and «B») almost half of the drugs were referred to «V» and «N» categories, and 67,6% of drugs of group «B» were referred to «E» category. According to expert VEN-analysis the predominant amount of drugs — 34 (51,5% of total used drugs) consist group «E». There are irrational use of drugs in central nervous system excitation syndrome and autonomic-visceral disturbances treatment. In general it was established that there are certain reserves for medicine therapy optimization in treatment of each syndrome of perinatal encephalopathy.

【 授权许可】

Unknown